SG Americas Securities, LLC
Broker-DealerPosition in CGC — Canopy Growth Corp
CIK 1313360
NEW YORK, NY
Position in CGC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$57,128
-$176,758 QoQ
Shares Held
60,135
-62.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 212 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $334,347,383 across 35 Drug Manufacturers - Specialty & Generic names. CGC ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,264,647 | $90,877,533 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
89,893 | $48,706,724 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,282,256 | $43,442,833 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
504,001 | $32,230,863 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
5,535,771 | $27,291,351 | |
| 6 | VTRS |
Viatris Inc
|
1,533,471 | $24,351,519 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
141,613 | $23,867,455 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
324,134 | $13,299,218 |
All Filings in CGC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,128 | 60,135 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $233,886 | 160,196 | Shares | Sole | 2025-10-23 | |
| 2024-03-31 | $739,591 | 85,700 | Shares | Sole | 2024-05-06 | |
| 2022-09-30 | $54,174 | 19,844 | Shares | Sole | 2022-10-31 | |
| 2020-06-30 | $1,580,803 | 97,822 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $3,605,000 | 250,000 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||